SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-005514
Filing Date
2023-08-10
Accepted
2023-08-10 16:30:45
Documents
51
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT phio_i10q-063023.htm   iXBRL 10-Q 526858
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER phio_ex3101.htm EX-31.1 10494
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER phio_ex3201.htm EX-32.1 4179
4 GRAPHIC image_001.jpg GRAPHIC 1237
  Complete submission text file 0001683168-23-005514.txt   2956814

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE phio-20230630.xsd EX-101.SCH 27063
6 XBRL CALCULATION FILE phio-20230630_cal.xml EX-101.CAL 35435
7 XBRL DEFINITION FILE phio-20230630_def.xml EX-101.DEF 99593
8 XBRL LABEL FILE phio-20230630_lab.xml EX-101.LAB 230107
9 XBRL PRESENTATION FILE phio-20230630_pre.xml EX-101.PRE 179458
45 EXTRACTED XBRL INSTANCE DOCUMENT phio_i10q-063023_htm.xml XML 331320
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 231160051
SIC: 2834 Pharmaceutical Preparations